MOLECULAR BIOLOGY CONSORTIUM (EIN 364334866) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

JOHN TANNER

Phone

7087760350

Tax Period

2024-07-01 to 2025-06-30

MOLECULAR BIOLOGY CONSORTIUM, founded in 1999, is a small nonprofit in the Public Safety sector that reported $532K in total revenue in fiscal year 2024. Expenses of $495K left a modest 7% surplus.

Mission

SCIENTIFIC RESEARCH AND TEACHING USING X-RAY CRYSTALLOGRAPHY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $181,491

Program Service Revenue $328,838

Investment Income $21,486

Other Revenue $0

TOTAL REVENUE $531,815

Expense Breakdown

Grants Paid $0

Salaries & Benefits $421,534

Fundraising Expenses $0

Program Expenses $374,392

Other Expenses $73,815

TOTAL EXPENSES $495,349

Year-over-Year Comparison

	2024	2023	Change
Revenue	$531,815	$501,234	+0.1%
Expenses	$495,349	$452,056	+0.1%
Net Income	$36,466	$49,178	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$12,500

Total Directors

$12,500

Key Employees

$300,607

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JACK TANNER	CHAIRMAN	1.00	Officer Director	$12,500	$0	$12,500
OLVE PEERSEN	CO-CHAIRMAN	1.00	Officer Director	$0	$0	$0
MAIR CHURCHILL	SECRETARY/TREASURER	1.00	Officer Director	$0	$0	$0
GERALD HAZELBAUER	SECRETARY/TREASURER (THRU JAN 2025)	1.00	Officer Director	$0	$0	$0
DAVED FREMONT	DIRECTOR	1.00	Director	$0	$0	$0
GIOVANNI GONZALEZ-GUTIERREZ	DIRECTOR	1.00	Director	$0	$0	$0
NICK SCHNICKER	DIRECTOR	1.00	Director	$0	$0	$0
JAY NIX	BEAMLINE DIRECTOR	40.00	Key Emp	$276,357	$24,250	$300,607

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$531,815	$495,349	$1,091,628	$36,466
2024	$501,234	$452,056	$1,063,573	$49,178
2023	$482,951	$452,293	$1,018,637	$30,658
2022	$446,784	$379,982	$979,055	$66,802
2021	$456,357	$361,819	$1,510,983	$94,538
2020	$379,201	$364,756	$1,419,698	$14,445
2019	$372,778	$383,808	$1,397,915	$-11,030
2018	$457,378	$403,112	$1,395,705	$54,266

MOLECULAR BIOLOGY CONSORTIUM